Coverage
-
January 09, 2014
The D.C. Circuit on Tuesday revived K-V Pharmaceutical Co.'s suit attempting to force the U.S. Food and Drug Administration to block pharmacies from producing cheaper compounded versions of K-V's preterm-birth prevention drug Makena.
1 other articles on this case.
View all »